Cancer and Medical Cannabis: A Powerful Combination Supported by Leading Organizations
Cancer is a formidable foe, taking on many forms and requiring a multifaceted approach to defeat. But one strategy that has gained increasing support from leading organizations is the use of medical cannabis.
Since the 1990s, the American Cancer Society (ACS) has been a strong advocate for medical cannabis research. In fact, the organization officially backed California’s Senate Bill 535 in 1997, which focused on studying the effectiveness of medical cannabis for treating AIDS-related wasting syndrome, glaucoma, and cancer. Despite controversy, the bill established a $1 million state research program at the University of California.
However, the ACS currently does not have an official stance on cannabis legislation. But other organizations have taken a more proactive approach.
In 2003, the American Nurses Association (ANA) passed a resolution supporting patients’ right to access medical cannabis under proper supervision. The ANA also recognized the harm caused by the criminalization of cannabis, making it difficult for patients to obtain the treatment they need. This resolution was a significant step towards acceptance of medical cannabis within the nursing community.
In 2006, the American Cannabis Nurses Association was formed, further promoting the use of medical cannabis. And in 2013, the ANA officially recognized cannabis nursing as a specialty practice within the organization.
The American Osteopathic Association (AOA) also recognizes the potential benefits of medical cannabis. In 2011, the AOA passed a resolution supporting well-controlled clinical studies on the use of cannabis for patients with significant medical conditions. And in 2018, the AOA reiterated its stance, calling for a review of the federal classification of cannabis to facilitate further research.
Even Health Canada, a federal institution similar to the U.S. Food and Drug Administration, has shown support for medical cannabis. As early as 1997, a Health Canada spokesperson stated that there is no difference between cannabis and other useful medicines derived from plants, such as morphine and aspirin. Health Canada has been heavily involved in regulating medical cannabis in Canada for over 20 years, implementing strict tracking systems to prevent illegal operations.
In 1999, researchers associated with the National Academy of Sciences Institute of Medicine published a report highlighting the potential therapeutic value of cannabinoid drugs, particularly THC, for pain relief and nausea control.
With the support of these leading organizations, it’s clear that medical cannabis is gaining recognition as a valuable tool in the fight against cancer and other medical conditions. As more research is conducted and laws are reevaluated, the potential benefits of medical cannabis will continue to be explored and utilized.
